ACADIA Pharmaceuticals Inc.
ACAD
$25.13
-$0.32-1.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 762.00M | 681.58M | 755.99M | 565.33M | 500.94M |
| Total Receivables | 119.69M | 113.71M | 104.70M | 110.36M | 110.39M |
| Inventory | 26.12M | 22.95M | 21.95M | 61.04M | 71.53M |
| Prepaid Expenses | 52.75M | 52.70M | 55.68M | 51.55M | 46.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 960.55M | 870.94M | 938.32M | 788.28M | 728.92M |
|
|
|||||
| Total Current Assets | 960.55M | 870.94M | 938.32M | 788.28M | 728.92M |
| Net Property, Plant & Equipment | 54.54M | 54.11M | 50.79M | 48.24M | 56.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 114.34M | 117.06M | 119.78M | 105.52M | 107.86M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.13M | 90.25M | 78.87M | 34.83M | 20.79M |
| Total Assets | 1.23B | 1.13B | 1.19B | 976.87M | 914.10M |
|
|
|||||
| Total Accounts Payable | 20.10M | 18.10M | 16.19M | 19.08M | 19.88M |
| Total Accrued Expenses | 298.23M | 264.02M | 254.44M | 236.33M | 227.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.69M | 11.37M | 9.96M | 8.95M | 10.47M |
| Total Finance Division Other Current Liabilities | -- | 9.05M | 114.28M | 79.58M | 79.58M |
| Total Other Current Liabilities | -- | 9.05M | 114.28M | 79.58M | 79.58M |
| Total Current Liabilities | 330.02M | 302.53M | 394.87M | 343.95M | 337.85M |
|
|
|||||
| Total Current Liabilities | 330.02M | 302.53M | 394.87M | 343.95M | 337.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.60M | 44.63M | 42.04M | 40.42M | 47.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.55M | 19.96M | 18.06M | 15.32M | 12.36M |
| Total Liabilities | 403.17M | 367.13M | 454.96M | 399.69M | 397.40M |
|
|
|||||
| Common Stock & APIC | 2.98B | 2.95B | 2.94B | 2.92B | 2.90B |
| Retained Earnings | -2.16B | -2.19B | -2.20B | -2.35B | -2.38B |
| Treasury Stock & Other | 406.00K | 437.00K | 292.00K | 858.00K | -339.00K |
| Total Common Equity | 822.38M | 765.24M | 732.79M | 577.18M | 516.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 822.38M | 765.24M | 732.79M | 577.18M | 516.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 822.38M | 765.24M | 732.79M | 577.18M | 516.70M |
|
|
|||||